Yi FF, Bai ZH, Xu XB, Qi XS. Advances in research of spontaneous splenorenal shunt in patients with liver cirrhosis.
Shijie Huaren Xiaohua Zazhi 2019;
27:1502-1508. [DOI:
10.11569/wcjd.v27.i24.1502]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Liver cirrhosis is the end stage of various chronic liver diseases. Spontaneous splenorenal shunt (SSRS) refers to abnormal blood vessels from the splenic vein to the renal vein, which are rich and thickened. SSRS formation may be due to the dilatation of pre-existing venules or neovascularization. SSRS can effectively reduce portal vein pressure, but it can also lead to a decrease of hepatic perfusion, which may be one of the reasons for insufficient hepatic perfusion after liver transplantation. In addition, toxic substances in the blood cannot be fully metabolized by the liver and directly enter the systemic circulation, leading to the development of hepatic encephalopathy. The treatment methods for SSRS include intervention and operation.
Collapse